Low doses of amitriptyline, pregabalin, and gabapentin are preferred for management of neuropathic pain in India: is there a need for revisiting dosing recommendations? |
Kamble, Sanjay Vasant
(Medical Affairs Department, Wockhardt Limited, Wockhardt Towers, Bandra Kurla Complex)
Motlekar, Salman Abdulrehman (Medical Affairs Department, Wockhardt Limited, Wockhardt Towers, Bandra Kurla Complex) D'souza, Lyndon Lincoln (Medical Affairs Department, Wockhardt Limited, Wockhardt Towers, Bandra Kurla Complex) Kudrigikar, Vinay Nanda (Medical Affairs Department, Wockhardt Limited, Wockhardt Towers, Bandra Kurla Complex) Rao, Sameer Eknath (Medical Affairs Department, Wockhardt Limited, Wockhardt Towers, Bandra Kurla Complex) |
1 | Peng PW, Li C, Farcas E, Haley A, Wong W, Bender J, et al. Use of low-dose pregabalin in patients undergoing laparoscopic cholecystectomy. Br J Anaesth 2010; 105: 155-61. DOI |
2 | Randinitis EJ, Posvar EL, Alvey CW, Sedman AJ, Cook JA, Bockbrader HN. Pharmacokinetics of pregabalin in subjects with various degrees of renal function. J Clin Pharmacol 2003; 43: 277-83. DOI |
3 | Semel D, Murphy TK, Zlateva G, Cheung R, Emir B. Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies. BMC Fam Pract 2010; 11: 85. DOI |
4 | Grice GR, Mertens MK. Gabapentin as a potential option for treatment of sciatica. Pharmacotherapy 2008; 28: 397-402. DOI |
5 | Arai YC, Matsubara T, Shimo K, Suetomi K, Nishihara M, Ushida T, et al. Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine. J Anesth 2010; 24: 407-10. DOI |
6 | Moulin D, Boulanger A, Clark AJ, Clarke H, Dao T, Finley GA, et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian pain society. Pain Res Manag 2014; 19: 328-35. DOI |
7 | Nascimento OJ, Pessoa BL, Orsini M, Ribeiro P, Davidovich E, Pupe C, et al. Neuropathic pain treatment: still a challenge. Neurol Int 2016; 8: 6322. |
8 | Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron 2006; 52: 77-92. DOI |
9 | Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpaa ML, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010; 85: S3-14. |
10 | Attal N, Cruccu G, Baron R, Haanpaa M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17: 1113-e88. DOI |
11 | Quintiles IMS Sales Data (Total Sales Audit and Secondary Sales Audit): Indian Pharmaceutical Market; Amitripyline, Gabapentin & Pregabalin; Moving Annual Total (MAT) August 2016. |
12 | NICE. Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings. Centre for clinical practice at NICE (UK). London, National Institute for Health and Clinical Excellence (UK). 2010, pp 1-138. |
13 | Liu Y, Qian C, Yang M. Treatment patterns associated with ACR-recommended medications in the management of Fibromyalgia in the United States. J Manag Care Spec Pharm 2016; 22: 263-71. DOI |
14 | Park HJ, Moon DE. Pharmacologic management of chronic pain. Korean J Pain 2010; 23: 99-108. DOI |
15 | Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet 2010; 49: 661-9. DOI |
16 | Nantz E, Liu-Seifert H, Skljarevski V. Predictors of premature discontinuation of treatment in multiple disease states. Patient Prefer Adherence 2009; 3: 31-43. |
17 | Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005; 116: 109-18. DOI |
18 | Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005; 6: 253-60. DOI |
19 | Dogra S, Beydoun S, Mazzola J, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain 2005; 9: 543-54. DOI |
20 | Backonja M, Glanzman RL. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 2003; 25: 81-104. DOI |
21 | Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, doubleblind, placebo-controlled trial. Arthritis Rheum 2005; 52: 1264-73. DOI |
22 | Vinik AI, Tuchman M, Safirstein B, Corder C, Kirby L, Wilks K, et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. Pain 2007; 128: 169-79. DOI |
23 | Patkar AA, Masand PS, Krulewicz S, Mannelli P, Peindl K, Beebe KL, et al. A randomized, controlled, trial of controlled release paroxetine in fibromyalgia. Am J Med 2007; 120: 448-54. DOI |
24 | Arnold LM, Goldenberg DL, Stanford SB, Lalonde JK, Sandhu HS, Keck PE Jr, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multi-center trial. Arthritis Rheum 2007; 56: 1336-44. DOI |
25 | Arnold LM, Crofford LJ, Martin SA, Young JP, Sharma U. The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia. Pain Med 2007; 8: 633-8. DOI |
26 | Agius AM, Jones NS, Muscat R. A randomized controlled trial comparing the efficacy of low-dose amitriptyline, amitriptyline with pindolol and surrogate placebo in the treatment of chronic tension-type facial pain. Rhinology 2013; 51: 143-53. |
27 | Freysoldt A, Fleckenstein J, Lang PM, Irnich D, Grafe P, Carr RW. Low concentrations of amitriptyline inhibit nicotinic receptors in unmyelinated axons of human peripheral nerve. Br J Pharmacol 2009; 158: 797-805. DOI |
28 | Kautio AL, Haanpaa M, Saarto T, Kalso E. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J Pain Symptom Manage 2008; 35: 31-9. DOI |
29 | Bowsher D. The management of postherpetic neuralgia. Postgrad Med J 1997; 73: 623-9. DOI |
30 | Kulshreshtha P, Gupta R, Yadav RK, Bijlani RL, Deepak KK. Effect of low-dose amitriptyline on autonomic functions and peripheral blood flow in fibromyalgia: a pilot study. Pain Med 2012; 13: 131-6. DOI |
31 | George RB, McKeen DM, Andreou P, Habib AS. A randomized placebo-controlled trial of two doses of pregabalin for postoperative analgesia in patients undergoing abdominal hysterectomy. Can J Anaesth 2014; 61: 551-7. DOI |
32 | Khurana G, Jindal P, Sharma JP, Bansal KK. Postoperative pain and long-term functional outcome after administration of gabapentin and pregabalin in patients undergoing spinal surgery. Spine (Phila Pa 1976) 2014; 39: E363-8. DOI |
33 | Nishihara M, Arai YC, Yamamoto Y, Nishida K, Arakawa M, Ushida T, et al. Combinations of low-dose antidepressants and low-dose pregabalin as useful adjuvants to opioids for intractable, painful bone metastases. Pain Physician 2013; 16: E547-52. |
34 | Zin CS, Nissen LM, O'Callaghan JP, Duffull SB, Smith MT, Moore BJ. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin. J Pain 2010; 11: 462-71. DOI |
35 | Hounnou P, Nicoucar K. Delayed onset of rotatory selfmotion perception, dysdiadochokinesia and disturbed eye pursuit caused by low-dose pregabalin. BMJ Case Rep [serial on the Internet]. [2014 Apr 11]. Available at http://casereports.bmj.com/content/2014/bcr-2013-201282.long. |
![]() |